Cordlife Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLIFF research report →
Companywww.cordlife.com
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It provides cord blood, cord lining, and cord tissue banking services comprising processing and storage of stem cells; and non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening, and newborn genetic screening services.
- CEO
- Xiaoling Chen
- IPO
- 2013
- Employees
- 596
- HQ
- Singapore, SG
Price Chart
Valuation
- Market Cap
- $18.04M
- P/E
- -6.57
- P/S
- 1.82
- P/B
- 0.35
- EV/EBITDA
- -5.32
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 56.37%
- Op Margin
- 6.72%
- Net Margin
- -27.58%
- ROE
- -5.67%
- ROIC
- 0.93%
Growth & Income
- Revenue
- $38.82M · 39.43%
- Net Income
- $-12,630,568 · 32.41%
- EPS
- $-0.05 · 32.51%
- Op Income
- $-15,094,727
- FCF YoY
- 95.34%
Performance & Tape
- 52W High
- $0.17
- 52W Low
- $0.07
- 50D MA
- $0.07
- 200D MA
- $0.10
- Beta
- 0.41
- Avg Volume
- 35
Get TickerSpark's AI analysis on CLIFF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CLIFF Coverage
We haven't published any research on CLIFF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLIFF Report →